Brian Helfand, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    GoPath
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Blue Earth Diagnostics
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Oncology)
    Ineligible company: 
    Blue Earth Diagnostics
  • Attribution: 
    Self
    Type of financial relationship: 
    Other (Oncology)
    Ineligible company: 
    Exact Sciences
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Ambry
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Oncology)
    Ineligible company: 
    Exact Sciences
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Oncology)
    Ineligible company: 
    Ambry Genetics
Return to Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP Inhibitors (2022) - English